Speaking with Ganesh Prasanna, Director of Ophthalmology at NIBR.
Novartis is taking its investigational gene therapy for a degenerative eye disease into clinical trials.
In this interview with Susie Gharib from Fortune, Vas Narasimhan, CEO of Novartis, shares his perspective on changing the culture within Novartis.
Learn how Novartis researchers are working to outsmart tumors.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.